Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002222 |
---|---|
Receipt number | R000002672 |
Scientific Title | Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell cancer |
Date of disclosure of the study information | 2009/07/21 |
Last modified on | 2016/03/31 15:33:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/07/18 07:53:34 | ||
2 | Update | 2009/11/09 18:25:55 | Recruitment status |
|
3 | Update | 2010/01/25 11:06:08 | Institutions |
|
4 | Update | 2010/05/06 13:53:30 | Recruitment status |
|
5 | Update | 2010/07/17 15:36:17 | Recruitment status |
|
6 | Update | 2011/07/19 13:57:44 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2014/01/21 08:16:32 | Email Institutions |
|
8 | Update | 2014/01/21 08:17:25 | Recruitment status |
|
9 | Update | 2014/07/15 16:57:51 | Last follow-up date |
|
10 | Update | 2016/03/31 15:33:50 | Recruitment status |